Hepatitis C There are a number of individuals who may be suffering from an illness and not even be aware they have an illness. One example of such illness is Hepatitis C (HCV). Hepatitis C is a severe disease of the liver. It is caused by the Hepatitis C virus (Centers for Disease Control and Prevention (CDC), 2015). As a result, Hepatitis C has been termed a silent epidemic (CDC, 2015). This is because a lot of individuals have Hepatitis C and don’t even realize they have the infection (CDC, 2015). As the infection begins to progress over time, it could cause acute issues to the liver (CDC, 2015). Those issues could be things like damage to the liver, the liver could fail to function, cirrhosis, or even cancer of the liver (CDC, 2015). However, screening for Hepatitis C will allow an individual to benefit from treatments that are available, hence eliminating the disease from the body and preventing the liver from undergoing any further damage (CDC, 2015). Fully understanding the background of Hepatitis C is challenging. This is because there are no blood samples over 50 years old which are around to test (Franciscus, 2016). Therefore, understanding how viruses evolved is impractical. Nevertheless, hepatitis C possibly could have existed for numerous years or longer prior to becoming type of strains that exists today (Franciscus, 2016). Although Hepatitis C may have been unearthed about 35 million years ago (Franciscus, 2016). Yet, this is simply a theory and it is
The Never event: Exposing the largest outbreak of hepatitis c in American healthcare history (McKnight & Bennington, 2008) begins telling the story of what should have been a “top-notch” cancer center with a doctor committed to saving lives. Memorial Hospital of Dodge County was expanding their cancer services, making access to services easier for the community. They wanted to keep their patients in town and help them avoid commutes to Omaha. They hired Dr. Tahir Ali Javed from Punjab, Pakistan; he educated and trained at well-known, prestigious facilities. Everything that was put into place, the new facility and outstanding physician, made it seem as though the cancer center was going to exceed the expectations that the hospital had in mind. However, malpractice, lack of compassion, and avoidance drove the center and the patients into the ground. After reading this novel, I was able to define compassionate care in my own terms and will provide examples of acts of compassionate care. As well as, discussing the principles of dignity and beneficence in regards to Dr. Javed and nurses in the clinic. Lastly, I will provide a testimony statement about the future care of patients.
As alarming as this may sound, this does affect you in your daily lives. A majority of the people reading this piece may be healthy beings, but there are no guarantees that this may not affect us in the future. Then again, other than hepatitis C, there are numerous other illnesses such as rheumatoid arthritis that we may encounter later in our lives. These diseases also have an alarming price tag associated with its treatments or medications.
This research paper is going to review today’s silent killer, the Hepatitis C virus. This paper will talk about the description of the disease, the signs and symptoms, the etiology and risk factors, diagnostic studies, treatments and prognosis of this disease. I had lived with this disease for over ten years before diagnosed so it is important to understand the signs and symptoms so the disease can be identified and a treatment plan can be identified as the sooner it is treated the more likely it will eradicate the disease.
Hepatitis C has been referred to as a "Silent Epidemic," since it usually progresses slowly over many years. Most people who are infected with hepatitis C are not aware of any noticeable symptoms for as long as one to two decades after they are infected. In fact, by the time symptoms appear, the virus has probably already begun to damage the liver. If the liver is injured and stops functioning, death will always be the outcome (Lieber). Liver failure from chronic hepatitis C is one of the most common causes of liver transplants in the United States.
HCV is known as the "silent killer" due it's long duration on the liver for 20-30 years (Hirsch, 2000).
Hayley is a 24yo, G1 P0, who was seen for a consultation due to hepatitis C. The patient does have a prior history of substance usage but states that she has been clean throughout the entire pregnancy. She does periodically use Goody powders prn and she was told to discontinue this. She also has issues with depression and anxiety and is on Zoloft 50 mg daily. She believes that a viral load was drawn but in looking at the labwork I do not have those results currently. Her hepatitis C antibody test was positive. Overall, she denies any complaints with the pregnancy to date.
14-Hepatitis C- is a slow-developing disease that can lead to liver damage and liver cancer as many as 30 years after infection. Remission can occur in up to 15 percent of people infected with HCV and four percent of infected people die from the virus.
Hepatitis is inflammation of the liver. There are currently five known viruses that cause can hepatitis (Microbiology, 10e). The hepatitis C virus (HCV) is transmitted through contact with the blood of an infected person; however, it is now more commonly spread among IV drug users that share needles. Healthcare workers are also at risk for contracting HCV, but with standard precautions, the risk is low. “Prior to 1992, some people acquired the HCV infection from transfusions of blood or blood products. Since 1992, all blood products have been screened for HCV, and cases of HCV due to blood transfusion now are extremely rare. HCV can be passed from mother to unborn child. Approximately 4 out of every 100 infants born to HCV-positive mothers
Hepatitis C has been referred to as a "Silent Epidemic," since it usually progresses slowly over many years. Most people who are infected with hepatitis C are not aware of any noticeable symptoms for as long as one to two decades after they are infected. In fact, by the time symptoms appear, the virus has probably already begun to damage the liver. If the liver is injured and stops functioning, death will always be the outcome (Lieber). Liver failure from chronic hepatitis C is one of the most common causes of liver transplants in the United States.
Hepatitis C virus (HCV) infection causes chronic liver. Over time, infections can lead to liver damage, liver cancer, and even liver failure.
About 4.1 million people in Americans have the positive antibody to hepatitis C virus (HCV), and about 75 percent have permeant infection. Additionally, most of the infections happened 20 to 40 years ago, before the finding of HCV. Hepatitis C increased from 7,000 to 13,000 deaths in 2005. Furthermore, HCV develops slowly which increases the risk of severe complications in the infected people. Identification, death, and treatment are predicted to affect 35,000 by 2030. The Center for Disease Control (CDC) used antiviral therapy with PEGylated in clinical trials (Kalichman, Washington, Kegler, Grebler, Kalichman, Cherry, & Eaton, 2015). The CDC recommends a HCV one time test for people born between 1945 and 1965. The objective of this study was to thoroughly evaluate the amount of substance abusers infected with hepatitis C in the United States. Additionally, to observe the treatment of HCV. Currently Medicaid and Medicare repayment standards for sofosbuvir were calculated in all states, including the District of Columbia. Medicaid and Medicare covered the drug based on the following conditions; liver disease stage, HIV, and drug use. Approximately 42 states reimbursed the following criteria up to 74 percent for the drug sofobuvir. About two-thirds of the United States restricted the treatment centered on prescriber type. About 88 percent included drug abuse in their sofosbuvir admissibility measures. Finally, 50 percent required a date of abstinence and 64 percent required
Hepatitis C is definitely not a public health crisis that needs emergency intervention in terms of the policy makers being pressured to make a decision urgently. However, thousands of citizens of the United States die on a yearly basis from this contagious disease (CDC, 2014). This makes it a serious public health issue. Hepatitis C is basically a liver disease that is contagious in nature and could be fatal if left untreated. According to the CDC website over 3 million Americans are infected with the disease (HCV), and “approximately 75%–85% of people who become infected with Hepatitis C virus develop chronic infection”. Hepatitis C is most commonly transmitted in the United States through IV drug use (CDC, 2014). Other modes of transmission includes blood transfusion or coming in contact with someone’s blood, accidental needlestick injuries among health care workers (e.g., nurses and phlebotomists), sexual contact (rare) and infants born to mothers who have the disease. These above medical and demographic facts make HCV a serious threat on public health.
About 4.1 million people in Americans have the positive antibody for hepatitis C virus (HCV), and about 75% of them are persistently infected and most of the infections happened d 20 to 40 years ago, before the finding of HCV. Hepatitis C increased from 7,000 to 13,000 deaths in 2005. Furthermore, HCV develops slowly which increases the risk for severe complications in the infected people. Identification, death, and treatment is predicted to affect 35,000 by 2030. The Center for Disease Control (CDC) used antiviral therapy with PEGylated in clinical trials. The CDC recommends a HVC one time test for people born between 1945 and 1965.They observed testing by birth. The objective of this study was to thoroughly evaluate the amount of substance abuser infected with hepatitis C in the United States. Additional to observe the treatment of HVC. Currently Medicaid and Medicare repayment standards for sofosbuvir were calculated in all states including the District of Columbia. Medicaid and Medicare covered the drug based on the following classes liver disease stage, HIV, and drug use. Approximately 42 states reimbursed the following criteria up to 74% for the drug sofobuvir. About two thirds of the United States restricted the treatment centered on prescriber type. About 88% included drug abuse in their sofosbuvir admissibility measures. Finally 50% required a dated of abstinence and 64% required drug test. The latest drug to HVC is called Sovaldi and it costs $84,000 for the 12
According to Baily, et al. (2009) lack of treatment to cure the disease will lead to a patient’s uncertainty on how the illness will present itself in the future. Thus, patients must face the unknown factors of their disease progression and manage life with their chronic illness. In Chronic Hepatitis C, tracking of outcomes and progressions are difficult, and disease trajectory varies from person to person (Baily, et al 2009). In addition, uncertainty stems from lack of knowledge of the disease, loss of control, and expectations of possible relapse of symptoms in the future.
Hepatitis C is a prevalent health care problem. According to the Centers of Disease Control and Prevention (CDC, 2016), approximately 2.7-3.9 million of the adult population in the United States is infected with hepatitis C virus (HCV). Some groups of people are at risk for Hepatitis C infection, including current injection drug users, people who received the blood transfusion before 1992, organ recipients from a donor who tested positive for hepatitis C virus, hemodialysis patients, and children born to a hepatitis C mother (CDC, 2016). Hepatitis C causes embarrassment and isolation from the society. Self-esteem and understanding of the